Overview:

Shenwei Pharmaceutical Co., Ltd. is one of the top 100 pharmaceutical companies in the country, one of the top 50 national patent medicine industries, a leading pharmaceutical enterprise in Hebei Province, and a national high-tech industrialization demonstration base for traditional Chinese medicine preparations. . It is a large-scale cross-regional and cross-industry joint-stock pharmaceutical enterprise focusing on the scientific research and production of modern traditional Chinese medicine. It integrates the scientific research and development, production and operation of medicines, health foods, traditional Chinese medicine pieces, and medicinal packaging, as well as pharmaceutical wholesale, retail, and export trade. It is the production base of traditional Chinese medicine injections, soft capsules and granules with the largest production and sales volume, the highest technical level, and has passed the national pharmaceutical production quality management (GMP) certification. It is one of the few large-scale modern traditional Chinese medicine enterprise groups in China that has fully passed the national GMP certification. . By the end of 2008, it had 6,000 employees.

Company development:

Strong R&D capabilities are the foundation for the sustainable development of Sunway Pharmaceuticals. Shenwei Pharmaceutical has established a postdoctoral research workstation and introduced senior professional and technical personnel, including postdoctoral fellows. Based on the principle of "inheriting the past and innovating without departing from the tradition", it is market-oriented, guided by science and technology, and takes the modernization of traditional Chinese medicine as the core to actively Carry out pharmaceutical research and clinical research on new traditional Chinese medicines and develop new products. Several new products come out every year, forming a new product pattern of "produce one generation, reserve one generation, develop one generation, and develop one generation". The national new drug Jiangzhi Tongluo Soft Capsules was included in the National High-tech Research and Development Plan (863) "Innovative Drugs and Modernization of Traditional Chinese Medicine" major science and technology projects, and was included in the "Jiangzhi Tongluo Soft Capsules High Technology" by the National Development and Reform Commission "Industrialization Demonstration Project" is a national key new product jointly recognized by the Ministry of Science and Technology and other four ministries.

Related events:

In 1970, the company’s predecessor, Nanwang Middle School Wuqi Chemical Plant, was established.

In 1973, this school-run factory was renamed Luancheng County Hongqi Pharmaceutical Factory.

In 1979, the company moved to Luancheng.

In 1984, after Li Zhenjiang took over the contract, he renamed the company Shijiazhuang Regional Pharmaceutical Factory.

On August 9, 1992, the company implemented joint-stock reform and Shijiazhuang Shenwei Pharmaceutical Co., Ltd. was officially established.

In 1996, the company purchased the "Shenwei" trademark and realized the unification of the company name and trademark.

In 1997, all employees bought out state-owned shares, becoming the first company in Hebei Province to complete the shareholding reform.

In September 2001, the modern traditional Chinese medicine extraction and injection project was approved by the State Planning Commission as the "High-tech Industrialization Demonstration Project for the Integration of Advanced Process Units of Traditional Chinese Medicine Preparations and Automatic Control of the Production Process" and was included in the national high-tech industry Development project plan.

In November 2001, the most modern, intelligent, pipelined and technologically advanced modern traditional Chinese medicine extraction workshop in China was completed and put into operation in Shenwei.

In May 2001, Sunway Pharmaceutical was awarded the National "May Day" Labor Award

Sunway Pharmaceutical Group

by the All-China Federation of Trade Unions.

In February 2002, the "Shenwei" trademark was rated as a well-known trademark in China.

In January 2003, all the company's dosage forms passed GMP certification, one and a half years ahead of the national regulations.

In November 2003, Sunway Pharmaceuticals’ “High-tech Industrialization Demonstration Project of Advanced Process Unit Integration and Automatic Production Process Control of Traditional Chinese Medicine Preparations” officially passed the national acceptance.

In December 2003, the "Shijiazhuang New Drug Research and Development Results Industrialization Base" project applied by Sunway Pharmaceuticals was included in the list of industrialization bases for the results of the "Tenth Five-Year Plan" National (863) Plan.

In April 2004, with the approval of the Hebei Provincial Department of Commerce and the Hebei Provincial Administration for Industry and Commerce, "Shijiazhuang Shenwei Pharmaceutical Co., Ltd." was reorganized into a wholly foreign-owned enterprise "Shenwei Pharmaceutical Co., Ltd." .

In June 2004, the company obtained the IMS certification certificate issued by the British BSI. It was the first group among Chinese patent medicine companies to pass the three-system integrated management system international certification of ISO9001, ISO14001, and OHSAS18001.

In December 2004, Sunway Pharmaceuticals was officially listed on the Main Board of the Stock Exchange of Hong Kong, becoming the first domestic modern Chinese medicine company listed on the Main Board of the Stock Exchange of Hong Kong.

In February 2005, Sunway Pharmaceuticals entered the list of the 200 listed companies with the largest market capitalization on the Hong Kong Stock Exchange.

In October 2005, the National Bureau of Statistics released information that Sunway Pharmaceuticals ranked among the top ten most profitable in the country's proprietary Chinese medicine manufacturing industry.

In November 2005, Sunway Pharmaceutical Co., Ltd. won the honor of "the most promising independent brand enterprise in China's manufacturing industry".

In November 2005, Sunway Pharmaceutical won the "2005 Top 100 Employers in China's Top Ten Industries Award".

In June 2006, Sunway Pharmaceuticals was approved to establish a postdoctoral research station

In June 2006, Sunway was selected into the "China's 500 Most Valuable Brands" promulgated by the World Brand Laboratory< /p>

In July 2006, Sunway Pharmaceuticals was once again selected as one of the top ten most profitable enterprises in key industrial industries in the country

In October 2006, Sunway Pharmaceuticals was rated as an outstanding enterprise in national harmonious labor relations

In April 2007, Sunway Pharmaceuticals was rated as one of the "Top 100 Pharmaceutical Industries in China". Sunway Pharmaceuticals has occupied the top spot for two consecutive years.

In August 2007, Sunway was rated as a "National Model Enterprise with Harmonious Labor Relations".

In October 2007, Sunway Pharmaceuticals won the title of "China Human Resources Best Employer of the Year 2007".

In October 2007, Sunway Pharmaceutical Group was selected into Forbes' 2007 Asia's 200 Best Small and Medium Enterprises list.

In November 2007, the opening ceremony of the Sunway Pharmaceutical Administration Center project located in Yanjiao Economic Development Zone, Sanhe City was held grandly.

In January 2008, Sunway Pharmaceuticals was selected into the "Forbes 2008 China's Potential Enterprises List".

In September 2008, Sunway won the 2008 "Corporate Social Responsibility Excellence Award" among Chinese pharmaceutical companies.

In October 2008, the famous performing artist Wang Gang became the spokesperson of Shenwei.

In December 2008, Sunway Pharmaceuticals won the honor of "2008 Hong Kong Outstanding Enterprise" and was the only pharmaceutical company selected.